Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disorder of lipid absorption and transport characterized by steatorrhea with foul-smelling stools from birth, diminished serum carotene and vitamin E and a combined deficiency of the pancreatic enzymes lipase and colipase. Patients are otherwise healthy and develop normally with no apparent pancreatic disease. There have been no further descriptions in the literature since 1990.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for combined pancreatic lipase-colipase deficiency.
2 publications have been identified in PubMed for combined pancreatic lipase-colipase deficiency. Research spans Case Report / Case Series (50%) and Basic Science / Preclinical (50%).
Curry GE (2025). [PMID: 40840699](https://pubmed.ncbi.nlm.nih.gov/40840699/). *J Lipid Res*. [Case Report / Case Series]
Hoffka G (2024). [PMID: 39265662](https://pubmed.ncbi.nlm.nih.gov/39265662/). *J Biol Chem*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:38 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about combined pancreatic lipase-colipase deficiency